Altimmune ALT
NASDAQ ALT
$2.12 -0.05 (-2.30%)
As of: Oct 23, 2026 · 3:59 PM EDT

Altimmune (ALT) Cash & Current Investments (2010 - 2026)

Updated

Altimmune (ALT) recorded Cash & Current Investments of $326.32 million in Q2 2026, up 78.2% from $183.15 million a year earlier but down 1.6% from the prior quarter.

Analysis

Altimmune (ALT) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Altimmune reported Cash & Current Investments of $273.5 million, up 107.3% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $131.93 million in FY2024 (-33.3%), $197.86 million in FY2023 (+7.0%), $184.91 million in FY2022 (-2.8%) and $190.34 million in FY2021 (-11.9%).
  • Quarterly Cash & Current Investments has ranged from $131.93 million in Q4 2024 to $331.58 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 39.6% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 121.2% in Q1 2026, against a decline of 33.3% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $331.58 million (Q1 2026), $273.5 million (Q4 2025) and $210.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Altimmune 392.21 Mn -750.01 Mn - 326.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 326.32 Mn
Mar 31, 2026 331.58 Mn
Dec 31, 2025 273.50 Mn
Sep 30, 2025 210.82 Mn
Jun 30, 2025 183.15 Mn
Mar 31, 2025 149.87 Mn
Dec 31, 2024 131.93 Mn
Sep 30, 2024 139.42 Mn
Jun 30, 2024 164.95 Mn
Mar 31, 2024 182.07 Mn
Dec 31, 2023 197.86 Mn
Sep 30, 2023 140.82 Mn
Jun 30, 2023 160.00 Mn
Mar 31, 2023 165.76 Mn
Dec 31, 2022 184.91 Mn
Sep 30, 2022 201.86 Mn
Jun 30, 2022 184.79 Mn
Mar 31, 2022 179.98 Mn
Dec 31, 2021 190.34 Mn
Sep 30, 2021 199.92 Mn
API Access

Altimmune Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALT&period=max&api_key=YOUR_API_KEY